← Zur Übersicht
Opfer

Laboratorios Roemmers SAICF

Website roemmers.com.ar
Gruppe
Aurora
Erfassungsdatum
Status
Online / unverändert
Land
Argentinien

Hinweise zur Einordnung

Dieser Eintrag dokumentiert eine Veröffentlichung der Gruppe. Ein Angriff oder Datenabfluss ist damit nicht unabhängig bestätigt.

Konfidenz ist eine heuristische Einschätzung. Prüfzeitpunkte beziehen sich auf die Anreicherung, nicht auf unabhängige Verifikation. Herkunft und Korrekturen finden Sie unter „Firmeninformationen & Datenherkunft“.

Ergänzende Einordnung
SektorGesundheitswesenhohe Sicherheit
Veröffentlichungsdatum01.10.2026, 02:00 Uhrhohe Sicherheit · OSINT-Abgleich
Firmeninformationen & Datenherkunft

Angaben der Ransomware-Gruppe

Unbestätigt

Quellentext als öffentliche Metadaten wiedergegeben. Die Aussagen wurden nicht unabhängig geprüft; Links sind ausgeblendet.

Laboratorios Roemmers SAICF — Argentina's #1 pharmaceutical company by revenue, with €1.669 billion in consolidated turnover, 6,890 employees, and 69 subsidiaries across 11 countries.

The exposed material includes:

4,207 employees' national identity numbers (CUIL) — Argentina's equivalent of a Social Security Number — combined with dates of birth, health insurance affiliations, and employer identifiers.

Psychotropic drug dispensing records — employee-by-employee tracking of who receives clonazepam, alprazolam, diazepam, and other psychiatric medications from the company nursing station. The most sensitive category: mental health data.

COVID-19 health tracking with clinical symptoms — individual symptom logs, doctor's notes, quarantine dates, and return-to-work clearances for employees who tested positive.

Pre-employment medical exam results with full DNI (national identity document) numbers.

PKCS#12 digital signing certificates for 7+ group companies — private keys used to sign electronic tax filings with AFIP (Argentina's tax authority).

82 GB of drug formulations — the complete pharmaceutical IP portfolio covering every product Roemmers manufactures, from API synthesis methods to finished-form specifications.

193 MB of API supplier qualification dossiers for 30+ international suppliers including CERBIOS (Switzerland), revealing the entire supply chain.

14 GB of internal drug pricing strategy and competitive intelligence.

Screenshot der Detailseite
Screenshot der Detailseite

Änderungsverlauf

Auch frühere Fassungen der Gruppenangaben sind unbestätigt. Links sind ausgeblendet.

2 Versionen

Aktualisiert · Version 2

11.10.2026, 07:04 Uhr · Opfer: Laboratorios Roemmers SAICF
Website · Screenshot dieser Version
Text dieser Version anzeigen

Laboratorios Roemmers SAICF — Argentina's #1 pharmaceutical company by revenue, with €1.669 billion in consolidated turnover, 6,890 employees, and 69 subsidiaries across 11 countries.

The exposed material includes:

4,207 employees' national identity numbers (CUIL) — Argentina's equivalent of a Social Security Number — combined with dates of birth, health insurance affiliations, and employer identifiers.

Psychotropic drug dispensing records — employee-by-employee tracking of who receives clonazepam, alprazolam, diazepam, and other psychiatric medications from the company nursing station. The most sensitive category: mental health data.

COVID-19 health tracking with clinical symptoms — individual symptom logs, doctor's notes, quarantine dates, and return-to-work clearances for employees who tested positive.

Pre-employment medical exam results with full DNI (national identity document) numbers.

PKCS#12 digital signing certificates for 7+ group companies — private keys used to sign electronic tax filings with AFIP (Argentina's tax authority).

82 GB of drug formulations — the complete pharmaceutical IP portfolio covering every product Roemmers manufactures, from API synthesis methods to finished-form specifications.

193 MB of API supplier qualification dossiers for 30+ international suppliers including CERBIOS (Switzerland), revealing the entire supply chain.

14 GB of internal drug pricing strategy and competitive intelligence.

Erstfassung · Version 1

01.10.2026, 08:52 Uhr · Opfer: Laboratorios Roemmers SAICF
Website · Screenshot dieser Version
Text dieser Version anzeigen

Laboratorios Roemmers SAICF — Argentina's #1 pharmaceutical company by revenue, with €1.669 billion in consolidated turnover, 6,890 employees, and 69 subsidiaries across 11 countries.

The exposed material includes:

4,207 employees' national identity numbers (CUIL) — Argentina's equivalent of a Social Security Number — combined with dates of birth, health insurance affiliations, and employer identifiers. A complete identity-theft package for the entire Argentine workforce.

Psychotropic drug dispensing records — employee-by-employee tracking of who receives clonazepam, alprazolam, diazepam, and other psychiatric medications from the company nursing station. The most sensitive category: mental health data.

COVID-19 health tracking with clinical symptoms — individual symptom logs, doctor's notes, quarantine dates, and return-to-work clearances for employees who tested positive.

Pre-employment medical exam results with full DNI (national identity document) numbers.

82 GB of drug formulations — the complete pharmaceutical IP portfolio covering every product Roemmers manufactures, from API synthesis methods to finished-form specifications.

193 MB of API supplier qualification dossiers for 30+ international suppliers including CERBIOS (Switzerland), revealing the entire supply chain.

14 GB of internal drug pricing strategy and competitive intelligence